CVE-2025-66095 is an SQL Injection vulnerability identified in the KiviCare clinic management system developed by Iqonic Design, affecting versions up to and including 3.6.13. The vulnerability stems from improper neutralization of special elements in SQL commands, which allows an attacker with low-level privileges (authenticated user) to inject malicious SQL code into the backend database queries. This injection can lead to unauthorized disclosure of sensitive data, as the CVSS vector indicates a confidentiality impact but no integrity or availability impact. The attack vector is network-based (remote), requires low attack complexity, and does not require user interaction. The vulnerability does not currently have publicly known exploits in the wild, but the presence of SQL Injection inherently poses a risk of data leakage or unauthorized data access. The lack of patches at the time of reporting means organizations must rely on compensating controls until vendor updates are released. The vulnerability is particularly critical in healthcare environments where patient data confidentiality is paramount. The technical details confirm that the vulnerability was reserved and published on November 21, 2025, and is tracked under CVE-2025-66095 with a medium severity rating and a CVSS score of 4.3.

For European organizations, especially those in the healthcare sector using KiviCare, this vulnerability could lead to unauthorized access to sensitive patient and clinic data, violating GDPR requirements for data protection and privacy. Although the vulnerability does not affect data integrity or system availability, the confidentiality breach could result in significant reputational damage, regulatory fines, and loss of patient trust. The attack requires authenticated access but only low privileges, which means insider threats or compromised user accounts could be leveraged to exploit this vulnerability. Given the critical nature of healthcare data and the increasing targeting of healthcare IT systems by cybercriminals, this vulnerability could be exploited to gather intelligence or conduct further attacks. The absence of known exploits currently reduces immediate risk but does not eliminate the threat, especially as attackers often develop exploits rapidly after disclosure. The impact is thus moderate but with potential for escalation if combined with other vulnerabilities or social engineering attacks.

Organizations should immediately inventory their KiviCare installations and verify the version in use. Until official patches are released by Iqonic Design, implement strict access controls limiting user privileges to the minimum necessary to reduce the risk of exploitation. Employ network segmentation to isolate KiviCare systems from broader network access. Apply Web Application Firewalls (WAFs) with custom rules to detect and block SQL Injection attempts targeting KiviCare endpoints. Conduct thorough input validation and enforce parameterized queries in any custom integrations or extensions of KiviCare. Monitor logs for unusual database query patterns or failed login attempts that could indicate exploitation attempts. Prepare to deploy vendor patches promptly once available and test updates in controlled environments prior to production deployment. Additionally, conduct user awareness training to reduce the risk of credential compromise that could facilitate exploitation.